(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-12 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 605797
Date | Daily Closing Price | Open | High | Low | Volume |
12 Thu Dec 2024 | 92.58 | 94.13 | 94.91 | 92.17 | 2.003 times |
11 Wed Dec 2024 | 94.47 | 95.32 | 97.00 | 93.41 | 0.862 times |
10 Tue Dec 2024 | 95.39 | 95.23 | 97.44 | 94.47 | 0.72 times |
09 Mon Dec 2024 | 94.57 | 96.29 | 97.00 | 94.44 | 0.899 times |
26 Tue Nov 2024 | 94.63 | 93.86 | 95.30 | 91.78 | 0.852 times |
26 Tue Nov 2024 | 94.63 | 93.86 | 95.30 | 91.78 | 0.852 times |
25 Mon Nov 2024 | 93.87 | 94.41 | 95.84 | 93.17 | 1.212 times |
22 Fri Nov 2024 | 94.15 | 96.78 | 98.34 | 94.11 | 1.095 times |
21 Thu Nov 2024 | 96.62 | 94.98 | 98.13 | 92.97 | 1.286 times |
20 Wed Nov 2024 | 94.81 | 94.16 | 95.02 | 92.66 | 0.935 times |
Stock of Blueprint Medicines (BPMC) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 92.4 as stoploss in an intra day buy trade for a target of 95.5. However, stock will show a bearish move below 92.4.
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 80.68 |
Downside Target | 83.91 |
Downside Target | 87.28 |
Downside Target | 91.78 |
Upside Target | 94.98 |
Upside Target | 96.50 |
Upside Target | 97.44 |
Upside Target | 98.34 |
Upside Target | 103.55 |
Upside Target | 108.40 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 90.69 |
Downside Intraday Target | 88.79 |
Upside Intraday Target | 95.96 |
Upside Intraday Target | 99.33 |
Upside Intraday Target | 94.06 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
12 Thu Dec 2024 | 92.58 | 96.29 | 97.44 | 92.17 | 5.26 times |
26 Tue Nov 2024 | 94.63 | 93.86 | 95.30 | 91.78 | 0.413 times |
26 Tue Nov 2024 | 94.63 | 94.41 | 95.84 | 91.78 | 0.366 times |
22 Fri Nov 2024 | 94.15 | 88.43 | 98.34 | 88.05 | 1.244 times |
15 Fri Nov 2024 | 88.69 | 102.07 | 103.55 | 88.41 | 0.721 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
12 Thu Dec 2024 | 92.58 | 96.29 | 97.44 | 92.17 | 0.22 times |
26 Tue Nov 2024 | 94.63 | 87.53 | 103.55 | 87.28 | 0.85 times |
31 Thu Oct 2024 | 87.51 | 91.63 | 94.98 | 80.68 | 1.055 times |
30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 94.4 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 94.4 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.